About this item:

57 Views | 35 Downloads

Author Notes:

Jyoti Sharma, Email: jyoti.sharma@piedmont.org

Jyoti Sharma: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. Jan McAlister: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. Niti R. Aggarwal: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. Janet Wei: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. Puja K. Mehta: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. Odayme Quesada: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. Deirdre Mattina: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. Nandita S. Scott: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. Erin D. Michos: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. Zainab Mahmoud: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. Karla Kurrelmeyer: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. Glaucia Maria Moraes De Oliveira: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing. Kathryn J. Lindley: Project administration, Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing.

All authors have no disclosures to make regarding funding or other relationships unless specifically noted. Dr. Odayme Quesada reports NIH K23HL1518677; Dr. Michos reports advisory boards for Novartis, Novo Nordisk, Amarin, Esperion, Bayer, Astra Zeneca, and Boehringer Ingeleheim. Given her role as Co-Editor of the American Journal of Preventive Cardiology, Dr. Michos had no input in the peer review process or decision regarding acceptance.

Subject:

Keywords:

  • Cholesterol management
  • Lipids
  • Women

Evaluation and management of blood lipids through a woman's life cycle.

Show all authors Show less authors

Tools:

Journal Title:

Am J Prev Cardiol

Volume:

Volume 10

Publisher:

, Pages 100333-100333

Type of Work:

Article | Final Publisher PDF

Abstract:

There are currently no sex-specific guidelines for evaluation and management of blood lipids. While previous guidelines acknowledge sex-specific risk enhancing factors for lipid management in women for CVD prevention, this review focuses on how lipids are impacted during normal hormonal changes throughout a woman's life cycle- during adolescence, pre-pregnancy, pregnancy, pre- and perimenopause, menopause, and at older ages. In this review, the authors focus on management of primary prevention of CVD by examining sex-specific cardiovascular risk factors at each stage and pay special attention to statin use, statin side effects and non-statin therapies. Women need to understand their personalized cholesterol goals and ally with their clinicians to ensure successful management. Additionally, we highlight the biases that exist when treating dyslipidemia in women and the special care clinicians should take to ensure appropriate and aggressive therapies are made available to female patients. Finally, the authors recommend future research should focus on increasing enrollment of women in lipid trials. This is of paramount importance in discovering sex-specific difference in lipid management.

Copyright information:

© 2022 The Authors. Published by Elsevier B.V.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/rdf).
Export to EndNote